Cloning and pharmacological characterization of CXCR1 and CXCR2 from Macaca fascicularis

被引:15
作者
Hipkin, RW [1 ]
Deno, G [1 ]
Fine, J [1 ]
Sun, YL [1 ]
Wilburn, B [1 ]
Fan, XD [1 ]
Gonsiorek, W [1 ]
Wiekowski, MT [1 ]
机构
[1] Schering Plough Corp, Res Inst, Dept Immunol, Kenilworth, NJ 07033 USA
关键词
D O I
10.1124/jpet.103.063131
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Two genes with high sequence homology to human CXCR1 (hCXCR1) and CXCR2 (hCXCR2) were cloned from blood of cynomolgus monkey ( Macaca fascicularis). Comparison of the expression pattern of these receptors in different species demonstrated that, like in humans, cynomolgus CXCR1 (cCXCR1) and CXCR2 (cCXCR2) are highly expressed in blood. Membranes from transfected BaF3 cells expressing cCXCR1 bind interleukin (IL)-8 with an affinity similar to hCXCR1 (K-d values, 170 +/- 87 and 103 +/- 37 pM, respectively) and show low binding affinity to Gro-alpha. Cynomolgus CXCR2 also binds hIL-8 but with somewhat higher affinity than the hCXCR2 (46 +/- 28 and 220 +/- 14 pM, respectively). Surprisingly, cCXCR2 has a reduced binding affinity to hGro-alpha (3.7 +/- 2.2 nM), a specific ligand of hCXCR2 (540 +/- 140 pM). Furthermore, the CXCR2-specific antagonist SB225002 [N-(2-hydroxy-4-nitrophenyl)-N'-(2-bromophenyl)urea] is 10-fold more potent in inhibiting IL-8 binding to hCXCR2 than to cCXCR2, suggesting that some of the observed differences in the amino acid sequences of the human and monkey receptor affect ligand binding sites or the conformation of the receptor. Both cynomolgus receptors were functionally active in inducing guanosine 5'-O-(3-thio)triphosphate exchange on membranes in response to IL-8 and Gro-alpha and in mediating chemotactic activity of recombinant BA/F3 cells in response to IL-8 and Gro-alpha. These results identify the products of the novel cynomolgus genes as functional homologs of hCXCR1 and hCXCR2.
引用
收藏
页码:291 / 300
页数:10
相关论文
共 37 条
[1]   CXC chemokines bind to unique sets of selectivity determinants that can function independently and are broadly distributed on multiple domains of human interleukin-8 receptor B - Determinants of high affinity binding and receptor activitation are distinct [J].
Ahuja, SK ;
Lee, JC ;
Murphy, PM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (01) :225-232
[2]   Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease [J].
Banks, C ;
Bateman, A ;
Payne, R ;
Johnson, P ;
Sheron, N .
JOURNAL OF PATHOLOGY, 2003, 199 (01) :28-35
[3]   Molecular cloning and sequencing of 25 different rhesus macaque chemokine cDNAs reveals evolutionary conservation among C, CC, CXC, and CX3C families of chemokines [J].
Basu, S ;
Schaefer, TM ;
Ghosh, M ;
Fuller, CL ;
Reinhart, TA .
CYTOKINE, 2002, 18 (03) :140-148
[4]   MOLECULAR CHARACTERIZATION OF THE INTERLEUKIN-8 RECEPTOR [J].
BECKMANN, MP ;
MUNGER, WE ;
KOZLOSKY, C ;
VANDENBOS, T ;
PRICE, V ;
LYMAN, S ;
GERARD, NP ;
GERARD, C ;
CERRETTI, DP .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 179 (02) :784-789
[5]   Neutrophil chemotactic activity of sputum from patients with COPD -: Role of interleukin 8 and leukotriene B4 [J].
Beeh, KM ;
Kornmann, O ;
Buhl, R ;
Culpitt, SV ;
Giembycz, MA ;
Barnes, PJ .
CHEST, 2003, 123 (04) :1240-1247
[6]   Pharmacology of N-(3,5-dichloro-1-oxido-4-pyridinyl)-8-methoxy-2-(trifluoromethyl)-5-quinoline carboxamide (SCH 351591), a novel, orally active phosphodiesterase 4 inhibitor [J].
Billah, MM ;
Cooper, N ;
Minnicozzi, M ;
Warneck, J ;
Wang, P ;
Hey, JA ;
Kreutner, W ;
Rizzo, CA ;
Smith, SR ;
Young, S ;
Chapman, RW ;
Dyke, H ;
Shih, NY ;
Piwinski, JJ ;
Cuss, FM ;
Montana, J ;
Ganguly, AK ;
Egan, RW .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 302 (01) :127-137
[7]  
BOZIC CR, 1994, J BIOL CHEM, V269, P29355
[8]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[9]   Characterization of the molecular interactions of interleukin-8 (CXCL8), growth related oncogen α (CXCL1) and a non-peptide antagonist (SB 225002) with the human CXCR2 [J].
Catusse, J ;
Liotard, A ;
Loillier, B ;
Pruneau, D ;
Paquet, JL .
BIOCHEMICAL PHARMACOLOGY, 2003, 65 (05) :813-821
[10]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099